In vivo effects of dexamethasone on the tumor growth of glucocorticoid-sensitive Fu5-derived rat hepatoma cells

Cancer Lett. 1991 Jul 4;58(3):211-9. doi: 10.1016/0304-3835(91)90103-o.

Abstract

We have previously demonstrated that BDS.1 cells are a minimal deviation rat hepatoma cell line that is hypersensitive to the anti-proliferative effects of glucocorticoids in vitro. When transplanted into athymic mice, exposure to dexamethasone reduced the initial growth rate and increased the latency time before detection of palpable BDS.1-derived tumors but did not affect the maximal growth rate, size and histology of the tumor. After collagenase dissociation, the in vitro growth of BDS.1-derived tumor cells was fully suppressed by dexamethasone. Exposure to insulin prevented the glucocorticoid inhibition of anchorage-independent growth of BDS.1 cell colonies in vitro and may therefore be one of the systemic factors that masks the long term in vivo growth response of glucocorticoids.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Carcinoma, Hepatocellular / drug therapy*
  • Cell Adhesion / drug effects
  • Cell Division / drug effects
  • Cell Line
  • Dexamethasone / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Antagonism
  • Insulin / pharmacology
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor II / pharmacology
  • Liver Neoplasms / drug therapy*
  • Mammary Neoplasms, Animal / drug therapy
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms, Experimental
  • Platelet-Derived Growth Factor / pharmacology
  • Rats
  • Transforming Growth Factor alpha / pharmacology
  • Tumor Cells, Cultured

Substances

  • Insulin
  • Platelet-Derived Growth Factor
  • Transforming Growth Factor alpha
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Dexamethasone